These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34873173)

  • 1. A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent.
    Chen Y; Gao P; Huang L; Tan X; Zhou N; Yang T; Qiu H; Dai X; Michael S; Tu Q; Huang N; Guo Z; Zhou J; Yang Z; Wu H
    Nat Commun; 2021 Dec; 12(1):7079. PubMed ID: 34873173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
    Curcio A; Torella D; Indolfi C
    Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium.
    Kural MH; Wang J; Gui L; Yuan Y; Li G; Leiby KL; Quijano E; Tellides G; Saltzman WM; Niklason LE
    Biomaterials; 2019 Aug; 212():28-38. PubMed ID: 31102854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nitric oxide-eluting and REDV peptide-conjugated coating promotes vascular healing.
    Zhang B; Qin Y; Wang Y
    Biomaterials; 2022 May; 284():121478. PubMed ID: 35366606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immobilization of nano Cu-MOFs with polydopamine coating for adaptable gasotransmitter generation and copper ion delivery on cardiovascular stents.
    Fan Y; Zhang Y; Zhao Q; Xie Y; Luo R; Yang P; Weng Y
    Biomaterials; 2019 Jun; 204():36-45. PubMed ID: 30875517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
    He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing.
    Wen L; Qiu H; Li S; Huang Y; Tu Q; Lyu N; Mou X; Luo X; Zhou J; Chen Y; Wang C; Huang N; Xu J
    Acta Biomater; 2024 Apr; 179():371-384. PubMed ID: 38382829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model.
    Salu KJ; Huang Y; Bosmans JM; Liu X; Li S; Wang L; Verbeken E; Bult H; Vrints CJ; De Scheerder IK
    Coron Artery Dis; 2003 Dec; 14(8):545-55. PubMed ID: 14646676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
    Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S
    Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
    Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
    Trials; 2012 May; 13():55. PubMed ID: 22559260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human recombinant activated protein C-coated stent for the prevention of restenosis in porcine coronary arteries.
    Lukovic D; Nyolczas N; Hemetsberger R; Pavo IJ; Pósa A; Behnisch B; Horak G; Zlabinger K; Gyöngyösi M
    J Mater Sci Mater Med; 2015 Oct; 26(10):241. PubMed ID: 26411437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents.
    Yang Z; Yang Y; Xiong K; Li X; Qi P; Tu Q; Jing F; Weng Y; Wang J; Huang N
    Biomaterials; 2015 Sep; 63():80-92. PubMed ID: 26093790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
    Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents.
    Yang Z; Yang Y; Zhang L; Xiong K; Li X; Zhang F; Wang J; Zhao X; Huang N
    Biomaterials; 2018 Sep; 178():1-10. PubMed ID: 29902532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arsenic trioxide eluting stents to prevent restenosis of injured iliac arteries in rabbits].
    Yang W; Ge JB; Liu HL; An Y; Liu XB; Tian Y; Qu XF; Li WM; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):14-8. PubMed ID: 16626542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.